IRB Approved at the Study Level: March 28, 2025
#43019288.0

You can help impact the Science of Brain Health

If you are aged 65-90, you may be eligible to participate in the REMIND-V Clinical Study.

The REMIND-V Study aims to evaluate investigational software innovations in brain health monitoring technology.

Whether you have normal thinking or mild memory challenges, your participation will help change the way doctors assess and manage cognitive health.

What to Expect

  • A single 2.5 hour visit, in the comfort of your home
  • Two simple cognitive assessments
  • A 20-minute, non-invasive EEG scan
  • A standard blood draw
  • $150 Amazon gift card for you, and $75 for your support person
  • NO experimental medications or procedures

You May Qualify if You

  • Are 65-90 years old
  • Have a person in your life who spends 8+ hours weekly with you and is willing to participate
  • Have either normal thinking or some cognitive challenges
Learn how to participate

Interested in participating in the REMIND-V Study?

Call or text us at +1 (786) 941-0300, or complete the form below to receive a call from our Clinical Trials Team.

IRB #43019288.0
Pl: Che Lucero, PhD ◆ Medical Director: Richard Caselli, MD
This study is registered with the FDA and funded by the National Institutes of Aging. Study 1390323.
ClinicalTrials.gov/study/NCT06809725
Fully funded by NIA award #R44AG078039-02, $1.338M